Global Blood Therapeutics, Inc.·4/A

Jun 21, 4:05 PM ET

Smith-Whitley Kim 4/A

4/A · Global Blood Therapeutics, Inc. · Filed Jun 21, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-06-01
Transactions
  • Award

    Restricted Stock Units

    2021-06-01+42,40042,400 total
    Common Stock (42,400 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Documents

2 files